344 related articles for article (PubMed ID: 21402146)
1. Luteolin inhibits Nrf2 leading to negative regulation of the Nrf2/ARE pathway and sensitization of human lung carcinoma A549 cells to therapeutic drugs.
Tang X; Wang H; Fan L; Wu X; Xin A; Ren H; Wang XJ
Free Radic Biol Med; 2011 Jun; 50(11):1599-609. PubMed ID: 21402146
[TBL] [Abstract][Full Text] [Related]
2. Acquisition of doxorubicin resistance in ovarian carcinoma cells accompanies activation of the NRF2 pathway.
Shim GS; Manandhar S; Shin DH; Kim TH; Kwak MK
Free Radic Biol Med; 2009 Dec; 47(11):1619-31. PubMed ID: 19751820
[TBL] [Abstract][Full Text] [Related]
3. Nrf2 knockdown by shRNA inhibits tumor growth and increases efficacy of chemotherapy in cervical cancer.
Ma X; Zhang J; Liu S; Huang Y; Chen B; Wang D
Cancer Chemother Pharmacol; 2012 Feb; 69(2):485-94. PubMed ID: 21842204
[TBL] [Abstract][Full Text] [Related]
4. Nrf2 enhances cell proliferation and resistance to anticancer drugs in human lung cancer.
Homma S; Ishii Y; Morishima Y; Yamadori T; Matsuno Y; Haraguchi N; Kikuchi N; Satoh H; Sakamoto T; Hizawa N; Itoh K; Yamamoto M
Clin Cancer Res; 2009 May; 15(10):3423-32. PubMed ID: 19417020
[TBL] [Abstract][Full Text] [Related]
5. Luteolin inhibits the Nrf2 signaling pathway and tumor growth in vivo.
Chian S; Thapa R; Chi Z; Wang XJ; Tang X
Biochem Biophys Res Commun; 2014 May; 447(4):602-8. PubMed ID: 24747074
[TBL] [Abstract][Full Text] [Related]
6. Gene expression profiling for analysis acquired oxaliplatin resistant factors in human gastric carcinoma TSGH-S3 cells: the role of IL-6 signaling and Nrf2/AKR1C axis identification.
Chen CC; Chu CB; Liu KJ; Huang CY; Chang JY; Pan WY; Chen HH; Cheng YH; Lee KD; Chen MF; Kuo CC; Chen LT
Biochem Pharmacol; 2013 Oct; 86(7):872-87. PubMed ID: 23933386
[TBL] [Abstract][Full Text] [Related]
7. Effect of stable inhibition of NRF2 on doxorubicin sensitivity in human ovarian carcinoma OV90 cells.
Manandhar S; Lee S; Kwak MK
Arch Pharm Res; 2010 May; 33(5):717-26. PubMed ID: 20512470
[TBL] [Abstract][Full Text] [Related]
8. Generation of a stable antioxidant response element-driven reporter gene cell line and its use to show redox-dependent activation of nrf2 by cancer chemotherapeutic agents.
Wang XJ; Hayes JD; Wolf CR
Cancer Res; 2006 Nov; 66(22):10983-94. PubMed ID: 17108137
[TBL] [Abstract][Full Text] [Related]
9. Luteolin sensitizes two oxaliplatin-resistant colorectal cancer cell lines to chemotherapeutic drugs via inhibition of the Nrf2 pathway.
Chian S; Li YY; Wang XJ; Tang XW
Asian Pac J Cancer Prev; 2014; 15(6):2911-6. PubMed ID: 24761924
[TBL] [Abstract][Full Text] [Related]
10. Involvement of Nrf2 activation in resistance to 5-fluorouracil in human colon cancer HT-29 cells.
Akhdar H; Loyer P; Rauch C; Corlu A; Guillouzo A; Morel F
Eur J Cancer; 2009 Aug; 45(12):2219-27. PubMed ID: 19524433
[TBL] [Abstract][Full Text] [Related]
11. [Effect of danshensu on redox state and relevant nuclear transcription factors in non-small cell lung cancer A549 cells].
Tao L; Wang S; Zhao Y; Chen W; Wang A; Lu Y
Zhongguo Zhong Yao Za Zhi; 2012 May; 37(9):1265-8. PubMed ID: 22803373
[TBL] [Abstract][Full Text] [Related]
12. Nrf2 mediates the resistance of human A549 and HepG2 cancer cells to boningmycin, a new antitumor antibiotic, in vitro through regulation of glutathione levels.
Zhang HX; Chen Y; Xu R; He QY
Acta Pharmacol Sin; 2018 Oct; 39(10):1661-1669. PubMed ID: 30287928
[TBL] [Abstract][Full Text] [Related]
13. Enhanced sensitivity of A549 cells to the cytotoxic action of anticancer drugs via suppression of Nrf2 by procyanidins from Cinnamomi Cortex extract.
Ohnuma T; Matsumoto T; Itoi A; Kawana A; Nishiyama T; Ogura K; Hiratsuka A
Biochem Biophys Res Commun; 2011 Oct; 413(4):623-9. PubMed ID: 21925486
[TBL] [Abstract][Full Text] [Related]
14. Role of the Nrf2-antioxidant system in cytotoxicity mediated by anticancer cisplatin: implication to cancer cell resistance.
Cho JM; Manandhar S; Lee HR; Park HM; Kwak MK
Cancer Lett; 2008 Feb; 260(1-2):96-108. PubMed ID: 18036733
[TBL] [Abstract][Full Text] [Related]
15. Nrf2 is involved in the effect of tanshinone IIA on intracellular redox status in human aortic smooth muscle cells.
Zhang HS; Wang SQ
Biochem Pharmacol; 2007 May; 73(9):1358-66. PubMed ID: 17303087
[TBL] [Abstract][Full Text] [Related]
16. Role of Nrf2 in the regulation of the Mrp2 (ABCC2) gene.
Vollrath V; Wielandt AM; Iruretagoyena M; Chianale J
Biochem J; 2006 May; 395(3):599-609. PubMed ID: 16426233
[TBL] [Abstract][Full Text] [Related]
17. Antioxidant and Nrf2 inducing activities of luteolin, a flavonoid constituent in Ixeris sonchifolia Hance, provide neuroprotective effects against ischemia-induced cellular injury.
Zhang YC; Gan FF; Shelar SB; Ng KY; Chew EH
Food Chem Toxicol; 2013 Sep; 59():272-80. PubMed ID: 23770353
[TBL] [Abstract][Full Text] [Related]
18. Emodin enhances cisplatin-induced cytotoxicity via down-regulation of ERCC1 and inactivation of ERK1/2.
Ko JC; Su YJ; Lin ST; Jhan JY; Ciou SC; Cheng CM; Chiu YF; Kuo YH; Tsai MS; Lin YW
Lung Cancer; 2010 Aug; 69(2):155-64. PubMed ID: 19962780
[TBL] [Abstract][Full Text] [Related]
19. HIF-1 alpha signaling is augmented during intermittent hypoxia by induction of the Nrf2 pathway in NOX1-expressing adenocarcinoma A549 cells.
Malec V; Gottschald OR; Li S; Rose F; Seeger W; Hänze J
Free Radic Biol Med; 2010 Jun; 48(12):1626-35. PubMed ID: 20347035
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia-induced resistance to cisplatin and doxorubicin in non-small cell lung cancer is inhibited by silencing of HIF-1alpha gene.
Song X; Liu X; Chi W; Liu Y; Wei L; Wang X; Yu J
Cancer Chemother Pharmacol; 2006 Dec; 58(6):776-84. PubMed ID: 16532342
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
